Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer
- Charu Aggarwal
- , Jeffrey C. Thompson
- , Austin L. Chien
- , Katie J. Quinn
- , Wei Ting Hwang
- , Taylor A. Black
- , Stephanie S. Yee
- , Theresa E. Christensen
- , Michael J. LaRiviere
- , Benjamin A. Silva
- , Kimberly C. Banks
- , Rebecca J. Nagy
- , Elena Helman
- , Abigail T. Berman
- , Christine A. Ciunci
- , Aditi P. Singh
- , Jeffrey S. Wasser
- , Joshua M. Bauml
- , Corey J. Langer
- , Roger B. Cohen
- University of Pennsylvania
- Guardant Health Inc
- University of Connecticut
Research output: Contribution to journal › Article › peer-review
95
Scopus
citations